Tom Winnifrith Bearcast: after the funding time to close the Shield Therapeutics short?
By Tom Winnifrith | Tuesday 13 December 2022
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
he Greek Hovel olive harvest is done and I am soon off to the press. Phew. In today's podcast I discuss Shield Therapeutics (STX), FinnCap (FCAP) and Argo Blockchain (ARB)
You must be a paid subscriber to listen to Bearcast
ShareProphets is reader-supported journalism
Join us for free and gain access to three articles per month
Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.